Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what research the Government is commissioning to assess the efficacy of Evusheld against covid-19 variants; when data from that research will be available; and if he will make a statement.

The UK Health Security Agency is undertaking in vitro testing on Evusheld’s effectiveness against the Omicron variant. The timing of these results is dependent on the testing assays. When available, the data will inform any decisions on this treatment, including procurement.